$599
BI Creates Metabolic Health Steering Committee; Reta Tops Ozempic; Lilly Initiates Elora CV Safety Study; Dexcom to Launch G7 15 Day in Canada; Viking and Beta Bionics Q3 ’26 Earnings
A series of cardiometabolic-related news items has been observed from Boehringer Ingelheim, Lilly, Viking, Dexcom, and Beta Bionics. Below, FENIX provides highlights and insights for the respective news items.
This content is for Read Less members only.
Already a member? Log in here
OR